Apr 14, 2016
It’s the scenario emerging biopharma organizations hope for: your company just discovered a groundbreaking piece of data, showed proof of concept in patients or an innovative animal experiment demonstrated an important piece of biology or your technology. Your...
Apr 12, 2016
When traditional biotech companies advance through the clinic towards the market, often there is an interest in acquiring a revenue stage product to jumpstart the commercial infrastructure. A module in our next Locust Walk Institute on May 4th and 5th will cover an...
Apr 5, 2016
As part of our upcoming Locust Walk Institute course on raising capital for companies, we put together a list of five mistakes an entrepreneur makes when raising capital. Each of these will be covered in depth during our course: The company story is too long Having a...
